Evidence map›Paper›PMID 36084473›Full record

ArticleBlood2022

Trafficking between clonally related peripheral T-helper cells and tissue-resident T-helper cells in chronic GVHD.

Xiaohui Kong, Xiwei Wu, Bixin Wang, Deye Zeng, Kaniel Cassady, Ubaydah Nasri, Moqian Zheng, Alyssa Wu, Hanjun Qin, Weimin Tsai and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Blood, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 14 citations in OpenAlex.

  1. Chronic graft-versus-host disease.Nature reviews. Disease primers · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Occurrence and role of Tph cells in various renal diseases.Molecular medicine (Cambridge, Mass.) · 2024
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Xiaohui KongDepartment of Immunology and Theranostics, Arthur Riggs Institute of Diabetes and Metabolism Research, The Beckman Research Institute of City of Hope, Duarte, CA.
Xiwei WuDepartment of Integrative Genomics Core, The Beckman Research Institute of City of Hope, Duarte, CA.
Bixin WangDepartment of Immunology and Theranostics, Arthur Riggs Institute of Diabetes and Metabolism Research, The Beckman Research Institute of City of Hope, Duarte, CA.
Deye ZengDepartment of Immunology and Theranostics, Arthur Riggs Institute of Diabetes and Metabolism Research, The Beckman Research Institute of City of Hope, Duarte, CA.
Kaniel CassadyDepartment of Immunology and Theranostics, Arthur Riggs Institute of Diabetes and Metabolism Research, The Beckman Research Institute of City of Hope, Duarte, CA.ORCID 0000-0001-8949-3507
Ubaydah NasriDepartment of Immunology and Theranostics, Arthur Riggs Institute of Diabetes and Metabolism Research, The Beckman Research Institute of City of Hope, Duarte, CA.
Moqian ZhengDepartment of Immunology and Theranostics, Arthur Riggs Institute of Diabetes and Metabolism Research, The Beckman Research Institute of City of Hope, Duarte, CA.
Alyssa WuDepartment of Immunology and Theranostics, Arthur Riggs Institute of Diabetes and Metabolism Research, The Beckman Research Institute of City of Hope, Duarte, CA.
Hanjun QinDepartment of Integrative Genomics Core, The Beckman Research Institute of City of Hope, Duarte, CA.
Weimin TsaiHematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Duarte, CA.
Amandeep SalhotraHematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Duarte, CA.
Ryotaro NakamuraHematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Duarte, CA.ORCID 0000-0002-9082-0680
Paul J MartinFred Hutchinson Cancer Research Center, Seattle, WA.ORCID 0000-0001-9051-1215
Defu ZengDepartment of Immunology and Theranostics, Arthur Riggs Institute of Diabetes and Metabolism Research, The Beckman Research Institute of City of Hope, Duarte, CA.ORCID 0000-0001-9585-1411
City Of Hope National Medical Center · USFujian Medical University · CNCity of Hope · USFred Hutch Cancer Center · US

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI XIWEI WU · 1985 to 2026
$86.3M
Role of autoreactivity in the pathogenesis of chronic GVHDR01AI066008 · NIAID · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI ZENG, DEFU · 2005 to 2020
$6.1M
PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activityR01CA228465 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI ZENG, DEFU · 2018 to 2022
$2.0M
NCI NIH HHS P30 CA033572NCI NIH HHS R01 CA228465NIAID NIH HHS R01 AI066008
6 · The paper itself

Abstract

Chronic graft-versus-host disease (cGVHD) is an autoimmune-like syndrome. CXCR5-PD-1hi peripheral T-helper (Tph) cells have an important pathogenic role in autoimmune diseases, but the role of Tph cells in cGVHD remains unknown. We show that in patients with cGVHD, expansion of Tph cells among blood CD4+ T cells was associated with cGVHD severity. These cells augmented memory B-cell differentiation and production of immunoglobulin G via interleukin 21 (IL-21). Tph cell expansion was also observed in a murine model of cGVHD. This Tph cell expansion in the blood is associated with the expansion of pathogenic tissue-resident T-helper (Trh) cells that form lymphoid aggregates surrounded by collagen in graft-versus-host disease (GVHD) target tissues. Adoptive transfer experiments showed that Trh cells from GVHD target tissues give rise to Tph cells in the blood, and conversely, Tph cells from the blood give rise to Trh cells in GVHD target tissues. Tph cells in the blood and Trh cells in GVHD target tissues had highly overlapping T-cell receptor α and β repertoires. Deficiency of IL-21R, B-cell lymphoma 6 (BCL6), or T-bet in donor T cells markedly reduced the proportions of Tph cells in the blood and Trh cells in GVHD target tissues and reduced T-B interaction in the lymphoid aggregates. These results indicate that clonally related pathogenic Tph cells and Trh cells traffic between the blood and cGVHD target tissues, and that IL-21R-BCL6 signaling and T-bet are required for the development and expansion of Tph and Trh cells in the pathogenesis of cGVHD.

Indexed as

Bronchiolitis Obliterans SyndromeGraft vs Host DiseaseAnimalsB-LymphocytesCD4-Positive T-LymphocytesChronic DiseaseHumansMiceT-Lymphocytes, Helper-Inducer

Identifiers

PMID36084473
PMCPMC9935547
OpenAlexW4295132182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.